Hans Peter Marti's picture

Hans Peter Marti

Professor, Professor of Nephrology I
  • E-mailHans-Peter.Marti@uib.no
  • Phone+4794030929
  • Visitor Address
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen

Faculty of Medcine: MED5, MED8 and MED11. Research line students (forskerlinje).

Postgraduate teaching of young nephrologists and internists

Academic article
  • Show author(s) (2024). Use of corticosteroids in Norwegian patients with immunoglobulin a nephropathy progressing to end-stage kidney disease: a retrospective cohort study. BMC Nephrology. 42.
  • Show author(s) (2024). Plasma proteome profiling reveals metabolic and immunologic differences between Anorexia Nervosa subtypes. Metabolism: Clinical and Experimental.
  • Show author(s) (2023). Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy. Physiological Reports.
  • Show author(s) (2023). The Association of Sarcopenia and Central Obesity with Mortality Risk in Patients with Chronic Kidney Disease – a 2-Year Observational Study. Current Developments in Nutrition (CDN).
  • Show author(s) (2023). Systems analyses of the Fabry kidney transcriptome and its response to enzyme replacement therapy identified and cross-validated enzyme replacement therapy-resistant targets amenable to drug repurposing. Kidney International. 803-819.
  • Show author(s) (2023). Renal Functional Response-Association With Birth Weight and Kidney Volume. Kidney International Reports. 1034-1042.
  • Show author(s) (2023). Proteomic analysis unveils Gb3-independent alterations and mitochondrial dysfunction in a gla <sup> −/−</sup> zebrafish model of Fabry disease. Journal of Translational Medicine.
  • Show author(s) (2023). Network-Based Assessment of Minimal Change Disease Identifies Glomerular Response to IL-7 and IL-12 Pathways Activation as Innovative Treatment Target. Biomedicines.
  • Show author(s) (2023). Kidney Dysfunction and Pathology in the Setting of Hemophagocytic Lymphohistiocytosis. Kidney International Reports.
  • Show author(s) (2023). Identification and characterization of aptameric inhibitors of human neutrophil elastase. Journal of Biological Chemistry.
  • Show author(s) (2023). Humoral Response After 6 or More Successive Doses of SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients-Should We Keep Vaccinating? Transplantation. e279-e280.
  • Show author(s) (2023). Glomerular transcriptomics predicts long term outcome and identifies therapeutic strategies for patients with assumed benign IgA nephropathy. Kidney International. 717-730.
  • Show author(s) (2023). Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts. BMC Nephrology. 15 pages.
  • Show author(s) (2023). Cystatin C proteoforms in chronic kidney disease. PLOS ONE. 13 pages.
  • Show author(s) (2023). Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy. Journal of Clinical Investigation. 15 pages.
  • Show author(s) (2023). A diet containing cod backbone proteins attenuated the development of mesangial sclerosis and tubular dysfunction in male obese BTBR ob/ob mice. European Journal of Nutrition. 3227-3240.
  • Show author(s) (2022). Reduced α-galactosidase A activity in zebrafish (Danio rerio) mirrors distinct features of Fabry nephropathy phenotype. Molecular Genetics and Metabolism Reports. 1-11.
  • Show author(s) (2022). Proteomic signature of tubulointerstitial tissue predicts prognosis in IgAN. BMC Nephrology. 1-10.
  • Show author(s) (2022). Intake of residuals from Atlantic cod attenuated blood pressure increase but did not delay development of kidney damage in obese Zucker fa/fa rats. Food & Nutrition Research (FNR). 1-11.
  • Show author(s) (2022). Imaging of Clear Cell Renal Carcinoma with Immune Checkpoint Targeting Aptamer-Based Probe. Pharmaceuticals. 19 pages.
  • Show author(s) (2022). Glomerular proteomic profiling of kidney biopsies with hypertensive nephropathy reveals a signature of disease progression. Hypertension Research.
  • Show author(s) (2022). Gene Expression Analysis in gla-Mutant Zebrafish Reveals Enhanced Ca<sup>2+</sup> Signaling Similar to Fabry Disease. International Journal of Molecular Sciences.
  • Show author(s) (2022). Chronic Kidney Disease from Polyvinylpyrrolidone Deposition in Persons with Intravenous Drug Use. American Society of Nephrology. Clinical Journal. 518-526.
  • Show author(s) (2022). Carbamylation of integrin αIIbβ3: The mechanistic link to platelet dysfunction in ESKD. Journal of the American Society of Nephrology. 1841-1856.
  • Show author(s) (2022). Association of redox and inflammation-related biomarkers with prognosis in IgA nephropathy: A prospective observational study. Free Radical Biology & Medicine. 62-70.
  • Show author(s) (2022). A multiomics disease progression signature of low-risk ccRCC. Scientific Reports. 1-15.
  • Show author(s) (2021). Ultrasound and Microbubbles Enhance Uptake of Doxorubicin in Murine Kidneys. Pharmaceutics.
  • Show author(s) (2021). Medication Prescription, Common Side-effects, and Nutritional Status are Associated in Patients With Chronic Kidney Disease. Journal of renal nutrition. 1-9.
  • Show author(s) (2021). Familial contributions to the association between low birth weight and risk of CKD in adult life. Kidney International Reports. 2151-2158.
  • Show author(s) (2021). Factors associated with nutritional risk in patients receiving haemodialysis assessed by Nutritional Risk Screening 2002 (NRS2002). Journal of Renal Care. 1-7.
  • Show author(s) (2021). Elevated Ambulatory Blood Pressure Measurements are Associated with a Progressive Form of Fabry Disease. High Blood Pressure & Cardiovascular Prevention. 309-319.
  • Show author(s) (2021). Cardiovascular changes in young renal failure patients. Clinical Kidney Journal (CKJ). 183-185.
  • Show author(s) (2021). Axl-inhibitor bemcentinib alleviates mitochondrial dysfunction in the unilateral ureter obstruction murine model. Journal of Cellular and Molecular Medicine. 7407-7417.
  • Show author(s) (2021). AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model. Physiological Reports. 1-11.
  • Show author(s) (2021). AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease. Cancer Cell International. 12 pages.
  • Show author(s) (2021). A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. 1-19.
  • Show author(s) (2020). The changing landscape of Fabry disease. Journal of the American Society of Nephrology. 569-576.
  • Show author(s) (2020). Intrauterine growth restriction, preterm birth and risk of end-stage renal disease during the first 50 years of life. Nephrology, Dialysis and Transplantation. 1157-1163.
  • Show author(s) (2020). Intrauterine growth restriction and risk of diverse forms of kidney disease during the first 50 years of life. American Society of Nephrology. Clinical Journal. 1413-1423.
  • Show author(s) (2020). Circulating inflammation-related factors are correlated with systemic redox status in IgA nephropathy; a case-control study. Free Radical Biology & Medicine. 10-18.
  • Show author(s) (2019). Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms. American Journal of Physiology - Renal Physiology (AJP).
  • Show author(s) (2019). Characterization of glomerular extracellular matrix in IgA nephropathy by proteomic analysis of laser-captured microdissected glomeruli. BMC Nephrology. 1-12.
  • Show author(s) (2019). Challenges and opportunities for nephrology in Western Europe. Kidney International. 1037-1040.
  • Show author(s) (2019). AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction. Physiological Reports. 1-20.
  • Show author(s) (2018). Systemic redox biomarkers and their relationship to prognostic risk markers in autosomal dominant polycystic kidney disease and IgA nephropathy. Clinical Biochemistry. 33-40.
  • Show author(s) (2018). Low birth weight associates with glomerular area in young male IgA nephropathy patients. BMC Nephrology. 1-10.
  • Show author(s) (2018). In vivo detection of chronic kidney disease using tissue deformation fields from dynamic MR imaging. IEEE Transactions on Biomedical Engineering. 1779-1790.
  • Show author(s) (2018). High rates of central obesity and sarcopenia in CKD irrespective of renal replacement therapy - An observational cross-sectional study. BMC Nephrology. 1-9.
  • Show author(s) (2018). Fine needle aspirates of kidneys: A promising tool for RNA sequencing in native and transplanted kidneys. BMC Nephrology. 1-9.
  • Show author(s) (2018). Expanding the utilization of formalin-fixed, paraffin-embedded archives: Feasibility of miR-Seq for disease exploration and biomarker development from biopsies with clear cell renal cell Carcinoma. International Journal of Molecular Sciences. 1-18.
  • Show author(s) (2017). Renal carcinoma/kidney progenitor cell chimera organoid as a novel tumorigenesis gene discovery model. Disease Models and Mechanisms. 1503-1515.
  • Show author(s) (2017). Renal Carcinoma/Kidney Progenitor Cell Chimera Organoid as a Novel Tumourigenesis Gene Discovery Model. Disease Models and Mechanisms. 1930-1942.
  • Show author(s) (2017). Pathomechanisms of renal Fabry disease. Cell and Tissue Research. 53-62.
  • Show author(s) (2017). Glomerular abundance of complement proteins characterized by proteomic analysis of laser-captured microdissected glomeruli associates with progressive disease in IgA nephropathy. Clinical Proteomics.
  • Show author(s) (2017). Disease progression modeling to evaluate the effects of enzyme replacement therapy on kidney function in adult patients with the Classic phenotype of Fabry disease. Kidney and Blood Pressure Research. 1-15.
  • Show author(s) (2017). Clear cell renal cell carcinoma is linked to epithelial-to-mesenchymal transition and to fibrosis. Physiological Reports. 1-18.
  • Show author(s) (2016). Transcriptome sequencing (RNAseq) enables utilization of formalin-fixed, paraffin-embedded biopsies with clear cell renal cell carcinoma for exploration of disease biology and biomarker development. PLOS ONE.
  • Show author(s) (2016). Renal fibrosis mRNA classifier: Validation in experimental lithium-induced interstitial fibrosis in the rat kidney. PLOS ONE.
  • Show author(s) (2016). RNA extraction for RNA sequencing of archival renal tissues. Scandinavian Journal of Clinical and Laboratory Investigation. 426-434.
  • Show author(s) (2016). Proteomic Analysis of Minimally Damaged Renal Tubular Tissue from Two-Kidney-One-Clip Hypertensive Rats Demonstrates Extensive Changes Compared to Tissue from Controls. Nephron. 70-80.
  • Show author(s) (2016). Next generation sequencing: A tool for this generation of nephrologists. European Medical Journal: Nephrology. 50-57.
  • Show author(s) (2016). Low birth weight and risk of progression to end stage renal disease in IgA nephropathy - A retrospective registry-based cohort study. PLOS ONE.
  • Show author(s) (2016). Exploring frailty and mild cognitive impairment in kidney transplantation to predict biomedical, psychosocial and health cost outcomes (GERAS): protocol of a nationwide prospective cohort study. Journal of Advanced Nursing.
  • Show author(s) (2016). End stage renal disease predicts increased risk of death in first degree relatives in the Norwegian population. PLOS ONE.
  • Show author(s) (2016). Development and confirmation of potential gene classifiers of human clear cell renal cell carcinoma using next-generation RNA sequencing. Scandinavian Journal of Urology. 452-462.
  • Show author(s) (2015). PTX3 Polymorphisms and Invasive Mold Infections after Solid Organ Transplantation. Clinical Infectious Diseases. 619-622.
  • Show author(s) (2015). Distinct protein signature of hypertension-induced damage in the renal proteome of two-kidney-one-clip (2K1C) rat model. Journal of Hypertension. 126-135.
  • Show author(s) (2015). CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation. Pharmacogenomics (London).
  • Show author(s) (2015). Bedeutung und management der Rezidive von Glomerulonephritiden im Nierentransplantat (Significance and management of recurrent glomerulonephritis in kidney transplantation). Therapeutische Umschau. 199-206.
  • Show author(s) (2014). Metzincins and related genes in experimental renal aging: towards a unifying fibrosis classifier across species. Nephrology, Dialysis and Transplantation. 1177-1185.
  • Show author(s) (2014). Correlation of serum and urinary matrix metalloproteases/tissue inhibitors of metalloproteases with subclinical allograft fibrosis in renal transplantation. Transplant Immunology. 1-6.
Academic lecture
  • Show author(s) (2021). Cleared Podocytes and Normal Kidney Function in Classical Fabry Males 15 Years After Start of Enzyme Replacement Therapy at Young Age.
  • Show author(s) (2019). Fabry Nephropathy: First mRNA-seq Findings from Kidney Biopsies Before and After Enzyme Replacement Therapy.
  • Show author(s) (2018). Primary Membranous Nephropathy: Glomerular RNA Sequencing from Archival Kidney Biopsies.
  • Show author(s) (2019). Challenging Anticoagulation in Advanced Renal Failure. American Journal of Medicine. 1258-1259.
Short communication
  • Show author(s) (2020). The case: Kidney injury in a patient receiving nivolumab. Kidney International. 1359-1360.
  • Show author(s) (2018). Klarcellet nyrekarsinom er knyttet til epitelial-til- mesenkymal overgang (EMT) og til fibrose. Best Practice Norge. Onkologi/hemtologi.
Letter to the editor
  • Show author(s) (2023). Response to Birth Weight and Renal Functional Reserve in Adults. Kidney International Reports. 1700-1701.
  • Show author(s) (2021). Low Immunization Rate in Kidney Transplant Recipients Also After Dose 2 of the BNT162b2 Vaccine: Continue to Keep Your Guard up! Transplantation. E80-E81.
  • Show author(s) (2015). Renal failure due to excessive intake of almonds in the absence of Oxalobacter Formigenes. American Journal of Medicine. e29-e30.
  • Show author(s) (2015). Renal Failure due to Excessive Intake of Almonds in the Absence of Oxalobacter formigenes. American Journal of Medicine.
Doctoral dissertation
  • Show author(s) (2023). From archival tissues to systems biology: Using transcriptomics to investigate the progression of kidney disease.
  • Show author(s) (2019). New methods clear the dust off old biopsies. RNA sequencing of FFPE kidney biopsies.
  • Show author(s) (2019). Epithelial-to-mesenchymal transition in clear cell renal cell cancer and renal fibrosis.
  • Show author(s) (2021). Synuclein Alpha Accumulation Drives Lysosomal Dysfunction in Fabry Podocytopathy.
  • Show author(s) (2020). Systems Analyses of Renal Fabry Transcriptome and Response to Enzyme Replacement Therapy (ERT) Identifies a Cross-Validated and Druggable ERT-Resistant Module.
  • Show author(s) (2018). Fine needle aspirates of kidneys are usable for RNA sequencing like regular core biopsies.
  • Show author(s) (2018). Fabry nephropathy: Transcriptome sequencing of microdissected renal compartments from archival kidney biopsies at baseline, and after 5 & 10 years of enzyme replacement therapy.
  • Show author(s) (2018). Expanding the utilization of formalin-fixed, paraffin-embedded archives: Feasability of miRNA-sequencing for disease exploration and biomarker development from biopsies with clear cell renal cell carcinoma.
  • Show author(s) (2016). Development and Confirmation of Gene Classifiers of Human Clear Cell Renal Cell Carcinoma Using Next-Generation Sequencing [Abstract].
  • Show author(s) (2016). Detection and Validation of Epithelial-to-Mesenchymal Transition(EMT) with Increased Expression of Axl and MMP-14 in Renal Cell Carcinoma.
  • Show author(s) (2018). Correction to: High rates of central obesity and sarcopenia in CKD irrespective of renal replacement therapy - An observational cross-sectional study. BMC Nephrology.
Academic literature review
  • Show author(s) (2021). International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Western Europe. Kidney International Supplements (KI Supplements). e106-e118.
  • Show author(s) (2020). Proteomics for the study of new biomarkers in Fabry disease: State of the art. Molecular Genetics and Metabolism. 86-93.
  • Show author(s) (2020). Fibrosis and cancer: shared features and mechanisms suggest common targeted therapeutic approaches. Nephrology, Dialysis and Transplantation. 1024-1032.
  • Show author(s) (2016). Nephropathology: A cornerstone for understanding and estimation of recent advances in glomerular diseases. BANTAO Journal. 60-63.

More information in national current research information system (CRIStin)

1. Single Cell Data-derived European Study for Personalised Management of Chronic Kidney Disease (CKD) in Children and Adolescents (NFR 2023-2028 to H.P. Marti)

2. Patient-tailored Management of Hypertensive Nephropathy through Digital technologies (Helse Vest Strategic Grant to H.P. Marti, 2021-2025)

3. Fabry Nephropathy (Industry support and previous Helse Vest funding)

4. Glomerular proteomics of posttransplant diabetes mellitus (Helse Sør-Øst support from RH in Oslo, own funding)

Professor I and Dr. h.c.

Leader of the Renal Research Group

Research groups